Gavin Dabrera
Overview
Explore the profile of Gavin Dabrera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
6502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pae R, Findlater L, Amlot R, Capelastegui F, Dabrera G, Humphreys C, et al.
BMC Public Health
. 2025 Feb;
25(1):421.
PMID: 39894838
Background: Growing numbers of people have been potentially exposed to avian influenza (AI), as the United Kingdom has managed the largest and most sustained series outbreaks in recent years. Antiviral...
2.
Sinnathamby M, Bourouphael T, Boateng J, Collonnaz M, Quinot C, Aziz N, et al.
Euro Surveill
. 2024 Nov;
29(45).
PMID: 39512168
We developed a new activity level setting threshold method, the mean standard deviation (MSD) method to quantify COVID-19 activity levels. This has been validated against the moving epidemic method (MEM),...
3.
Mesle M, Brown J, Mook P, Katz M, Hagan J, Pastore R, et al.
Lancet Respir Med
. 2024 Aug;
12(9):714-727.
PMID: 39127051
Background: By March, 2023, 54 countries, areas, and territories (hereafter CAT) in the WHO European Region had reported more than 2·2 million COVID-19-related deaths to the WHO Regional Office for...
4.
Quinot C, Kirsebom F, Andrews N, Stowe J, Ramsay M, Dabrera G, et al.
Lancet Reg Health Eur
. 2024 Jul;
43:100975.
PMID: 39027896
No abstract available.
5.
Dabrera G
Curr Opin Infect Dis
. 2024 Jul;
37(5):431-435.
PMID: 38975631
Purpose Of Review: This review aims to discuss the current state of human infections with Avian Influenza A (H5) and (H9) viruses, to support awareness of the global epidemiology among...
6.
Aziz N, Twohig K, Sinnathamby M, Zaidi A, Aliabadi S, Groves N, et al.
Influenza Other Respir Viruses
. 2024 May;
18(5):e13308.
PMID: 38736251
No abstract available.
7.
Kirsebom F, Andrews N, Stowe J, Dabrera G, Ramsay M, Lopez Bernal J
EClinicalMedicine
. 2024 Apr;
71:102587.
PMID: 38618208
Background: The Sanofi/GSK AS03-adjuvanted (VidPrevtyn Beta) vaccine and the Pfizer-BioNTech mRNA (Comirnaty Original/Omicron BA.4-5) bivalent vaccine were offered to adults aged 75 years and over in England from 3rd April...
8.
Kirsebom F, Harman K, Lunt R, Andrews N, Groves N, Aziz N, et al.
Lancet Reg Health Eur
. 2023 Dec;
35:100755.
PMID: 38115965
Background: Since the first emergence of Omicron BA.1 in England in November 2021, numerous sub-lineages have evolved. In September 2022, BA.5 dominated. The prevalence of BQ.1 increased from October, while...
9.
Sinnathamby M, Zaidi A, Twohig K, Aliabadi S, Aziz N, Groves N, et al.
Influenza Other Respir Viruses
. 2023 Nov;
17(11):e13204.
PMID: 38019701
The emergence of the SARS-CoV-2 Beta (B.1.351) variant in November 2020 raised concerns of increased transmissibility and severity. We describe the epidemiology of 949 confirmed SARS-CoV-2 Beta variant cases in...
10.
Seghezzo G, Nash S, Aziz N, Hope R, Bernal J, Gallagher E, et al.
Epidemiol Infect
. 2023 Oct;
151:e189.
PMID: 37905583
Since the emergence of Omicron variant of SARS-CoV-2 in late 2021, a number of sub-lineages have arisen and circulated internationally. Little is known about the relative severity of Omicron sub-lineages...